Volume 13, Number 6—June 2007
Murine Typhus in Children, South Texas1
Children from South Texas were evaluated for immunoglobulin G to Rickettsia typhi, the causative agent of murine typhus. Of 513 children, 8.6% of those 1–5 years of age, 13.3% of those 6–11 years of age, and 13.8% of those 12–17 years of age had positive results.
Rickettsia typhi causes murine typhus in humans, a febrile illness with headache and rash. Despite the disappearance of R. typhi from most of the United States, 9–72 cases per year of murine typhus were reported to the Texas Department of State Health Services from 1994 to 2003 (1). An earlier study of 200 cases reported in Texas from 1980 through 1984 found that 29% of the patients resided in Nueces County (2). Children with murine typhus often have nonspecific signs and symptoms that mimic those of common viral infections, and the illness usually resolves without antimicrobial drug therapy (3,4). We believe that many cases go unrecognized and unreported. The objective of this study was to determine the seroprevalence of R. typhi in children residing in Nueces County and to assess whether the seroprevalence increases with age due to a greater chance of exposure over time.
Driscoll Children’s Hospital is a tertiary care pediatric teaching hospital located in Corpus Christi, Texas, the seat of Nueces County. A convenience sample of serum residuals was obtained from blood samples of children seen in the hospital, its clinic, and its emergency department. Serum was evaluated by use of an indirect immunofluorescence antibody (IFA) test kit for immunoglobulin G (IgG) to R. typhi and R. rickettsii (Focus Diagnostics, Cypress, CA, USA). Specimen preparation, testing, quality control, and interpretation were done as described in the package insert (www.focusdx.com). Reciprocal titers >64 were considered positive. Endpoint titers were not determined. Testing was performed by the laboratory technician who does all rickettsia assays for the hospital.
No patient information was collected other than age, sex, and county of residence. Only serum residuals from children residing in Nueces County who were 1 to 17 years of age were included. A minimum of 150 serum residuals were obtained from children in each of 3 age groups (1–5, 6–11, and 12–17 years), with ≈50% from each age group being boys. χ2 analysis and the Fisher exact test were used to compare frequencies between groups. The Institutional Review Board at Driscoll Children’s Hospital approved this research project; informed consent was not required.
Samples (n = 513) were obtained between May 1, 2005, and August 31, 2006; 47.2% were from boys. There were 152 samples from children 1–5 years of age (mean age 2.7 years; 75 boys), 180 from children 6–11 years of age (mean age 8.2 years; 91 boys), and 181 from children 12–17 years of age (mean age 14.4 years; 76 boys).
Of the 152 samples from children 1–5 years of age, 13 (8.6%) were positive for R. typhi IgG and 6 (3.9%) were positive for R. rickettsii IgG. Four (67%) of the 6 patient samples positive for R. rickettsii IgG were also positive for R. typhi IgG. Of the 180 samples from children 6–11 years of age, 24 (13.3%; p = 0.18 compared with children 1–5 years of age; power = 0.21) were positive for R. typhi IgG and 13 (7.2%) were positive for R. rickettsii IgG. Eleven (85%) of 13 patient samples positive for R. rickettsii IgG were also positive for R. typhi IgG. Of the 181 samples from children 12–17 years of age, 25 (13.8%; p = 0.18 compared with children 1–5 years of age; power = 0.25) were positive for R. typhi IgG and 1 (0.6%) was positive for R. rickettsii IgG. The 1 patient sample that was positive for R. rickettsii IgG was also positive for R. typhi IgG. Thus, 62 (12%) of 513 samples tested had IgG reactive to R. typhi, and 20 (3.9%) had IgG reactive to R. rickettsii. χ2 analysis for trend showed no difference in R. typhi seroprevalence between the 3 age groups (p = 0.28; power = 0.27).
On the basis of this study, ≈9%–14% of children in Nueces County have antibodies reactive to R. typhi. Seroprevalence appeared to increase with age. This trend did not reach statistical significance, but the power was insufficient to resolve a difference between the 3 age groups. Our results are similar to those of seroepidemiologic studies of R. typhi conducted in Texas and other areas of the world. Wiggers and Stewart (5) found that 15.7% of serum samples from an adult population in East Texas were positive for R. typhi.
Of the 20 samples positive for R. rickettsii IgG, 16 (80%) were also positive for R. typhi IgG and probably represent cross-reactivity, which can occur within and between the typhus fever and spotted fever groups (6). Because R. rickettsii is not endemic in South Texas, the 4 samples positive for R. rickettsii IgG and negative for R. typhi IgG may represent cases of R. felis, for which no test kit was available. R. felis can cause murine typhus–like illness, as reported, for example, in a patient from South Texas (7). In addition, opossums and cat fleas in South Texas demonstrate a higher infection rate with R. felis than R. typhi (8). It is also possible that the children in our study with test results positive for R. rickettsii IgG but negative for R. typhi IgG may have traveled outside South Texas to an area where R. rickettsii is endemic. They may also represent cases of infections caused by other Rickettsia spp., such as R. prowazekii, R. parkerii, and R. amblyommii.
Our study had several limitations and potential sources of bias due to the testing and sampling methods used, and these may have led to an overestimation of R. typhi seroprevalence. First, the reading of slides is subjective for indirect IFA assays; thus, it is possible that some negative results were deemed positive. We did not have >1 observer validate the results, but we did use a laboratory technician who was experienced at performing the tests. Second, a reciprocal titer >64 was considered positive per the test kit instructions. Use of a higher reciprocal titer for the cutoff may increase the specificity of the test and reduce the number of false-positive results. However, IgG titers decline over time (9), and we wanted to make sure we detected low-level titers that may have resulted from infections that occurred years ago. Third, we did not obtain medical or travel histories for the children. It is possible that some with positive test results may have had contact with other rickettsia and that their test result was positive due to cross-reactivity. Last, the convenience sample of specimens may not be representative of the Nueces County population as a whole because the specimens were not obtained through a randomized process.
Endemic murine typhus continues to occur frequently in South Texas children, as shown by the high rate of R. typhi seroprevalence that we found. Most cases probably go undiagnosed and spontaneously resolve. During the 1930s and 1940s, when murine typhus was more common, investigators evaluating the seroprevalence of R. typhi estimated that ≈700 people per year in San Antonio, Texas, were infected; whereas, the peak number of cases reported by the San Antonio Health Department in 1944 was only 91 (10). Physicians practicing in or near R. typhi–endemic areas need to consider murine typhus in the differential diagnosis of children with a febrile illness without a clear source of infection. R. typhi can be a cause of fever of unknown origin in hospitalized children who live in or travel to areas where this rickettsia is endemic, and it is important to know that effective antibiotic treatment is available (3,4).
Dr Purcell is pediatric pharmacy operations manager for CHRISTUS Santa Rosa Health Care; adjunct associate professor of pharmacy practice, University of the Incarnate Word Feik School of Pharmacy; and adjunct associate professor of pediatrics, University of Texas Health Science Center at San Antonio. His clinical research focus is respiratory syncytial virus, community-acquired methicillin-resistant Staphylococcus aureus, and Rickettsia typhi infections in children.
This study was supported by a research grant from the Coastal Bend Health Education Center, a component of the Texas A&M University System Health Science Center.
- Human cases of reportable zoonotic diseases in Texas. Zoonosis Control Group. Texas Department of State Health Services. [cited 2005 Nov 20]. Available from http://www.dshs.state.tx.us/idcu/healthzoonosis/disease
- Taylor JP, Betz TG, Rawlings JA. Epidemiology of murine typhus in Texas, 1980 through 1984. JAMA. 1986;255:2173–6.
- Fergie JE, Purcell K, Wanat D. Murine typhus in South Texas Children. Pediatr Infect Dis J. 2000;19:535–8.
- Whiteford SF, Taylor JP, Dumler JS. Clinical, laboratory, and epidemiologic features of murine typhus in 97 Texas children. Arch Pediatr Adolesc Med. 2001;155:396–400.
- Wiggers RJ, Stewart RS. Ownership of cats or dogs does not increase exposure to Rickettsia typhi. Tex Med. 2002;98:56–7.
- Traub R, Wisserman CL, Farhang-Azad A. The ecology of murine typhus: a critical review. Trop Dis Bull. 1978;75:237–317.
- Schriefer ME, Sacci JB, Dumler JS. Identification of a novel rickettsial infection in a patient diagnosed with murine typhus. J Clin Microbiol. 1994;32:949–54.Bullen MGAzad AF
- Boostrom A, Beier MS, Macaluso JA, Macaluso KR, Sprenger D, Hayes J, et al. Geographic association of Rickettsia felis–infected opossums with human murine typhus, Texas. Emerg Infect Dis. 2002;8:549–54.
- Halle S, Dasch GA. Use of a sensitive microplate enzyme-linked immunosorbent asay in a retrospective serological analysis of a laboratory population at risk to infection with typhus group rickettsia. J Clin Microbiol. 1980;12:343–50.
- Davis DE, Pollard M. Prevalence of typhus complement-fixing antibodies in human serums in San Antonio, Texas. Public Health Reports U.S. 1946;61:928–31.
Suggested citation for this article: Purcell K, Fergie J, Richman K, Rocha L. Murine typhus in children, South Texas. Emerg Infect Dis [serial on the Internet]. 2007 Jun [date cited]. Available from http://wwwnc.cdc.gov/eid/article/13/6/06-1566.htm
1This work was presented in part as a poster at the Pediatric Academic Societies’ annual meeting in San Francisco, CA, USA, on May 1, 2006.